Mostra el registre parcial de l'element

dc.contributor.authorBlázquez, E.
dc.contributor.authorRodríguez, C.
dc.contributor.authorRódenas, J.
dc.contributor.authorNavarro, N.
dc.contributor.authorRosell, R.
dc.contributor.authorPina-Pedrero, S.
dc.contributor.authorCampbell, J.M.
dc.contributor.authorSibila, M.
dc.contributor.authorSegalés, J.
dc.contributor.authorPujols, J.
dc.contributor.authorPolo, J.
dc.contributor.otherProducció Animalca
dc.date.accessioned2020-03-30T09:33:55Z
dc.date.available2020-03-30T09:33:55Z
dc.date.issued2019-10-12
dc.identifier.citationBlázquez, E., C. Rodríguez, J. Ródenas, N. Navarro, R. Rosell, S. Pina-Pedrero, and J.M. Campbell et al. 2019. "UV-C Irradiation Is Able To Inactivate Pathogens Found In Commercially Collected Porcine Plasma As Demonstrated By Swine Bioassay". Veterinary Microbiology 239: 108450. Elsevier BV. doi:10.1016/j.vetmic.2019.108450.ca
dc.identifier.issn0378-1135ca
dc.identifier.urihttp://hdl.handle.net/20.500.12327/653
dc.description.abstractLiquid porcine plasma is an animal origin raw material for the manufacturing process of spray-dried porcine plasma that is used in pig nutrition worldwide. In previous studies we found that the application of ultraviolet light C (UV-C) in liquid plasma that was inoculated with a variety of bacteria or viruses of importance in the swine industry can be considered as redundant safety steps because in general achieve around 4 logs reduction for most of these pathogens. However, the final validation of the UV-C light as safety feature should be conducted with commercial liquid plasma and using the pig bioassay model. As a first objective, the potential infectivity of a raw liquid plasma product collected from an abattoir was tested by means of a swine bioassay. We used Porcine circovirus 2 (PCV-2), a ubiquitous virus that has been systematically detected by PCR in porcine plasma at abattoirs as selection criteria for commercial liquid plasma lot. As a second aim of the study, the effects of different doses of UV-C irradiation on the selected raw liquid plasma were assayed in the animal bioassay. Moreover, other swine infecting agents, including Porcine reproductive and respiratory syndrome virus (PRRSV), were also determined in the original plasma and monitored in the inoculated animals. Pigs negative for PCV-2 and PRRSV genome and antibodies were allotted to one of five groups (6 to 8 pigs/ group) and injected intra-peritoneally with 10 mL of their assigned inoculum at 50 d of age. Negative control pigs (group 1) were injected with PBS. Positive control pigs (group 5) were injected with a PCV-2 inoculum. Groups 2, 3 and 4 were injected with liquid porcine plasma that had been subjected to 0 (raw plasma), 3000 or 9000 J/L UV-C irradiation, respectively. Group 2 pigs (0 J/L UV-C) got infection by PRRSV but no PCV-2 infection or seroconversion. However, one pig from group 2 seroconverted to Rotavirus A (RVA) and Hepatitis E virus (HEV) and three group 2 pigs seroconverted to Porcine parvovirus (PPV). Groups 1, 3 and 4 pigs showed no evidence of infection or seroconversion associated with the tested viruses or any other pathogens found in the liquid plasma before UV-C irradiation. Group 5 pigs developed PCV-2 infectivity as expected. UV-C irradiation of liquid plasma at 3000 and 9000 J/L was effective in preventing PRRSV and other pathogens transmission. Moreover, raw liquid plasma was non-infectious for PCV-2 in naïve pigs.ca
dc.format.extent5ca
dc.language.isoengca
dc.publisherElsevierca
dc.relation.ispartofVeterinary Microbiologyca
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internationalca
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.titleUV-C irradiation is able to inactivate pathogens found in commercially collected porcine plasma as demonstrated by swine bioassayca
dc.typeinfo:eu-repo/semantics/articleca
dc.description.versioninfo:eu-repo/semantics/publishedVersionca
dc.rights.accessLevelinfo:eu-repo/semantics/openAccess
dc.embargo.termscapca
dc.subject.udc619ca
dc.identifier.doihttps://doi.org/10.1016/j.vetmic.2019.108450ca
dc.contributor.groupSanitat Animalca


Fitxers en aquest element

 
 

Aquest element apareix en la col·lecció o col·leccions següent(s)

Mostra el registre parcial de l'element

Attribution-NonCommercial-NoDerivatives 4.0 International
Excepte que s'indiqui una altra cosa, la llicència de l'ítem es descriu com http://creativecommons.org/licenses/by-nc-nd/4.0/
Comparteix a TwitterComparteix a LinkedinComparteix a FacebookComparteix a TelegramComparteix a WhatsappImprimeix